Johnson & Johnson announced on Wednesday that the Canadian health agency has fully approved the single-shot COVID-19 vaccine for people over the age of 18, and is the first in the world to fully approve the vaccine.
Janssen Pharma statement Health Canada approved the vaccine on Wednesday as follows: Research It has been shown to be 85% effective in preventing severe illness and prevent COVID-19-related hospitalization and death 28 days after injection.
Paul Stoffels, Vice Chairman and Chief Scientific Officer of the Johnson & Johnson Executive Committee, said this meant “the first major regulatory approval” for the vaccine.
Mathai Mammen, Global Head of Research and Development at Janssen, said he was “happy” with Health Canada’s decision to approve the company’s vaccine.
“As vaccination rates continue to rise, vaccines that prevent serious illness and prevent COVID-related hospitalizations and deaths help reduce the burden on the healthcare system and are important for people in Canada and around the world. It’s an option, “says Mamen.
Health Canada has previously approved the use of the Johnson & Johnson COVID-19 vaccine. Temporary order..
Canada also last month approved the use of Pfizer BioNTech’s COVID-19 vaccine for children aged 5 to 11 years who were not previously eligible for the vaccine. On November 9, the country also approved Booster shot Of Pfizer vaccine for people over 18 years old.
In October, the US Food and Drug Administration (FDA) also approved Booster Johnson and Johnson vaccines in the United States to all individuals over the age of 18. It can be given at least 2 months after the first inoculation.
On November 19, the FDA also approved the COVID-19 vaccine booster from Pfizer-BioNTech and Moderna for all people over the age of 18. Both Pfizer and Modana booster vaccines can be given 6 months after the first series of doses. Prior to its announcement, booster shots of both vaccines were available for certain high-risk profiles.